Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-08

Clinical Trial Update: Dextrose Gel Does Not Prevent Neonatal Hypoglycemia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating dextrose gel to prevent neonatal hypoglycemia did not prevent the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextrose Gel (dextrose gel)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Hypoglycemia, Infant, Small for Gestational Age | Phase 2, Phase 3 | Status: COMPLETED